Comprehensive and accurate screening of 283 genes
Sema4 Expanded Carrier Screen (ECS) is a comprehensive carrier test that screens for more than 280 genetic diseases with sequencing technologies that are >99% accurate. This panel also includes 101 genes associated with Jewish founder mutations for comprehensive coverage for patients with Jewish ancestry.
With Sema4 Expanded Carrier Screen, carrier screening may be easily customized to address specific clinical needs. Testing can be performed for all 283 genes, a smaller subset of genes, or even just one gene. Additional molecular and biochemical diagnostic testing is also available for all genes on our carrier screening panels.
- In-network with the majority of national and regional insurers
- Patient-friendly billing policies, including competitive self-pay prices and financial assistance programs
- We appeal coverage determinations on behalf of patients if precertification or pre-authorization requests are denied
- Patients can track their tests, view results, and access educational materials through the Sema4 Patient Portal
What’s coming soon
We will soon launch Expanded Carrier Screen with Personalized Residual Risk. This advanced carrier screening will offer analysis of up to 502 genes and utilizes proprietary technology to identify a patient’s molecular ancestry on a genome-wide level for tailored, personalized residual risk. Such information is critical for providers to better understand a patient’s chance for passing on inherited disease and further builds on Sema4’s gold standard Expanded Carrier Screen.